Algo version: 0.98b
Gland Pharma Limited is listed at the NSE Exchange
Gland Pharma Limited [GLAND.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—General

Is Gland Pharma Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Gland Pharma Limited pays dividends. Last time was Sunday 29th of September 2024 where the investors holding the stock on Friday 16th of August 2024 were paid INR20 per share. Over the last 1 times between 2024 and 2024, Gland Pharma Limited has paid INR20 with an average of INR20 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Gland Pharma Limited 10 years ago, but if you had invested on Friday 20th of November 2020 when the price was INR1 819.55, you would have made a profit of INR86.45 per share or 4.75%

Yes, the average daily trading liquidity for Gland Pharma Limited is INR398 844 thousand. You should therefore be able to get in and out of your positions relatively fast.

Gland Pharma Limited has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.49, the company's ability to pay off the debt is good. Gland Pharma Limited has a good net profit margin of 13.64% and should have high tolerances against inflation.

We have calculated the inflation risk for Gland Pharma Limited to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.